Risk of second cancers doubled in CLL 1 Sep 2011 0 comments The risk of second cancers in patients with chronic lymphocytic leukaemia is more than doubled compared to the general population, with the rate of melanoma increased seven-fold, a new study…
Intrathecal vincristine 1 Apr 2011 0 comments A fatal medication error in which a US woman was given the antineoplastic drug vincristine intrathecally has sparked a renewed call to eliminate the syringe as a method for vincristine…
TPO agonist subsidised 1 Apr 2011 0 comments The thrombopoietin receptor agonist romiplostim is listed on the Pharmaceutical Benefits Scheme from today for the initial and continuing treatment of adult patients with chronic immune…
